DISC1 overexpression promotes non-small cell lung cancer cell proliferation.
Oncotarget. 2017 May 22;:
Authors: Wang S, Chen YY, Li YP, Gu J, Gu SD, Shi H, Li XS, Lu XN, Li X, Zhang SL, Yu KJ, Liu K, Ji LL
Abstract
Neuropsychiatric disorder-associated disrupted-in-schizophrenia-1 (DISC1) activates Wnt/β-catenin signaling by inhibiting glycogen synthase kinase 3 beta (GSK3β) phosphorylation, and may promote neural progenitor cell and pancreatic β-cell proliferation. The present study found that DISC1 promotes non-small cell lung cancer (NSCLC) cell growth. Western blotting and immunohistochemistry analyses showed that DISC1 was highly expressed in NSCLC cell lines and patient tissues. DISC1 expression was negatively associated with phosphorylated (p-) GSK3β, but positively correlated with a more invasive tumor phenotype and predicted poor NSCLC patient prognosis. siRNA-mediated DISC1 silencing increased p-GSK3β expression and decreased expression of β-catenin and Cyclin D1, while DISC1 upregulation produced the opposite results. DISC1 knockdown also reduced NSCLC cell proliferation rates in vitro. These results suggest that DISC1 promotes NSCLC growth, likely through GSK3β/β-catenin signaling, and that DISC1 may function as an oncogene and novel anti-NSCLC therapeutic target.
PMID: 28591745 [PubMed - as supplied by publisher]
http://ift.tt/2rPbHwT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου